General Information of This Metabolic Reaction (MR) (ID: MR001300)
Formula
SVG example
Hydrolysis
Reactant Ixazomib Product Ixazomib metabolite M2
Reactant Info Product Info
Metabolic Type Hydrolysis - Hydrolysis
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001301 Ixazomib Ixazomib metabolite M1 Hydrolysis - Hydrolysis Ixazomib [1]
MR001304 Ixazomib Ixazomib metabolite M20 Oxidation - Oxidation Ixazomib [1]
MR001303 Ixazomib Ixazomib metabolite M3 Hydrolysis - Hydrolysis Ixazomib [1], [2]
MR001299 Ixazomib Ixazomib metabolite M5 Hydrolysis - Hydrolysis Ixazomib [1]
MR001302 Ixazomib Ixazomib metabolite M6 Unclear Ixazomib [1]
MR001305 Ixazomib ML790286 Oxidation - Dehydrogenation Ixazomib [3]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001296 Ixazomib metabolite M5 Ixazomib metabolite M2 Unclear Ixazomib [1]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001298 Ixazomib metabolite M2 Ixazomib metabolite M1 Unclear Ixazomib [1]
References
1 Biotransformation of [(14)C]-ixazomib in patients with advanced solid tumors: characterization of metabolite profiles in plasma, urine, and feces Cancer Chemother Pharmacol. 2018 Nov;82(5):803-814. doi: 10.1007/s00280-018-3671-z.
2 Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism Int J Mol Sci. 2021 Oct 27;22(21):11595. doi: 10.3390/ijms222111595.
3 U. S. FDA Label -Ixazomib

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.